Artia Global Partners’s AbbVie ABBV Stock Holding History

Artia Global Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,500	Closed	-$3.15M	–	49
2026 Q1	$3.15M	Hold	14,500	–	–	0.63%	31
2025 Q4	$3.31M	Hold	14,500	–	–	0.47%	31
2025 Q3	$3.36M	Hold	14,500	–	–	0.53%	27
2025 Q2	$2.69M	Buy	+14,500	New	+$2.69M	0.65%	21
2024 Q2	–	Sell	-90,821	Closed	-$16.5M	–	47
2024 Q1	$16.5M	Hold	90,821	–	–	3.32%	6
2023 Q4	$14.1M	Hold	90,821	–	–	4.09%	7
2023 Q3	$13.5M	Hold	90,821	–	–	5.63%	5
2023 Q2	$12.2M	Hold	90,821	–	–	4.22%	6
2023 Q1	$14.5M	Hold	90,821	–	–	5.35%	5
2022 Q4	$14.7M	Buy	+90,821	New	+$13.9M	5.59%	6

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Artia Global Partners's ABBV Position: Q2 2026 in Review

Artia Global Partners sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 14,500 shares — an estimated $3.15M sold.

Artia Global Partners first reported a position in ABBV in Q4 2022 and held it in 10 quarters. The position peaked at $16.5M in Q1 2024. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Artia Global Partners reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
Artia Global Partners sold 14,500 AbbVie shares in Q2 2026, an estimated $3.15M.
Artia Global Partners first reported a position in AbbVie in Q4 2022 and held it in 10 quarters.
Artia Global Partners's AbbVie position peaked at $16.5M in Q1 2024.
4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Artia Global Partners's 13F filing for Q2 2026, filed 14 Aug 2026.